Fungal Infections in Immunocompromised Travelers

Immunocompromised patients represent an increasing group of travelers, for business, tourism, and visiting friends and relatives. Those with severe cellular immunodeficiency (advanced human immunodeficiency virus infection and transplant recipients) display the highest risk of fungal infections. Int...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2013-03, Vol.56 (6), p.861-869
Main Authors: Lortholary, Olivier, Charlier, Caroline, Lebeaux, David, Lecuit, Marc, Consigny, Paul Henri
Format: Article
Language:English
Subjects:
Bacteriology
Biological and medical sciences
Coccidioidomycosis
Disease risks
Fungal infections
Histoplasmosis
HIV Infections - complications
Human health and pathology
Humans
Immune system
Immunocompromised Host
Immunocompromised hosts
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunology
Immunopathology
Infections
Infectious diseases
Life Sciences
Medical sciences
Microbiology and Parasitology
Mycoses
Mycoses - diagnosis
Mycoses - epidemiology
Physicians
Risk factors
Transplantation
Travel
Travelers
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immunocompromised patients represent an increasing group of travelers, for business, tourism, and visiting friends and relatives. Those with severe cellular immunodeficiency (advanced human immunodeficiency virus infection and transplant recipients) display the highest risk of fungal infections. International travel is less risky in most other types of immunodeficiency (except those with neutropenia). A systematic visit in a travel clinic for immunocompromised patients traveling to the tropics ensures that the specific risks of acquiring fungal infections (and others) are understood. When immunocompromised hosts return to their area of residence, a nonbacteriologically documented, potentially severe, febrile pneumonia, with or without dissemination signs (skin lesions, cytopenia) should alert for travel-acquired fungal infection, even years after return. Localized subcutaneous nodule may be also ascribed to fungal infection. Finally, infectious diseases physicians should be aware of major clinical patterns of travel-acquired fungal infection, as well as the fungi involved, and risk factors according to the geographical area visited.
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/cis935